Czech Company News

28 May 1995

Spolana Neratovice, the producer of drugs and chemicals in Neratovice in the central Bohemia region of the Czech Republic, recorded gross profit for 1994 of 350 million koruna ($13.1 million), according to the CTK news agency's Business News. First quarter 1995 exports amounted to 97 million koruna.

- Rhone-Poulenc, the French drugs and chemicals group, achieved turnover of 850 million koruna ($31.6 million) in the Czech Republic for 1994, the news agency reports. Sales for the current year are expected to increase to 1 billion koruna.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight